Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-26 @ 3:52 AM
NCT ID:
NCT01172418
Group ID:
EG001
Title:
Thymoglobulin and Alemtuzumab
Description:
Group II: A new steroid avoidance protocol in which 1 dose of 1 mg/kg of Thymoglobulin® is to be infused at surgery followed by 1 dose of alemtuzumab (Campath-1H) at 0.3 mg/kg within 24 hours. No further antibody therapy will be used.
Alemtuzumab: used in conjunction with Thymoglobulin as combined Induction.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
25
Serious Number At Risk:
100
Other Number Affected:
8
Other Number At Risk:
70
Study:
NCT01172418
Results Section:
NCT01172418
Adverse Events Module:
NCT01172418